chrisvoncsefalvay/vaers-outcomes huggingface dataset:
16 year old male child received the first Moderna vaccine; A spontaneous report was received from a consumer concerning a 16-year-old, male patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) resulting in the event, 16 year old male child received the first Moderna vaccine.  The patient's medical history was not provided.  Concomitant medications were not reported.  On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 30 Dec 2020, the patient was 16 years of age when he received the mRNA-1273 vaccine. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event, 16 year old male child received the first Moderna vaccine, was considered resolved on 30 Dec 2020.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273, lot # unknown.  There were no reported AEs associated with this case of product administered to patient of inappropriate age.
13 hours after receiving the vaccine I had a fever of 101*,  an extreme headache,  extreme body aches, and  a very sore  injection sight.  The sore injection sight lasted 7 days.  The other symptoms lasted approximately 60 hours.
Mild Pain at injection site starting 10 hours after injection given, lasting for two days. Fatigue starting 24 hours after the injection and lasting for one day.
itching around the injection site turning red right afterward and when she scratched it, the; red around the injection site; little tender at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching around the injection site turning red right afterward and when she scratched it, the), VACCINATION SITE PAIN (little tender at the injection site) and VACCINATION SITE ERYTHEMA (red around the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (little tender at the injection site). On 21-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching around the injection site turning red right afterward and when she scratched it, the) and VACCINATION SITE ERYTHEMA (red around the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching around the injection site turning red right afterward and when she scratched it, the), VACCINATION SITE PAIN (little tender at the injection site) and VACCINATION SITE ERYTHEMA (red around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Organic vinegar, alcohol. First put organic vinegar on it and then started using alcohol to try to alleviate the itching.
Urticarial rash that started from the face and trunk and spread to the whole body. Started as small papules, increased in size to macules and developed into hives. It is itchy. No fever and no mucosal involvement.
Back stiffness and pain, body aches, jaw ache, toothache and sore arm.
Patient was admininstered an expired dose of Daptacel with no AE; Initial information regarding an unsolicited valid non-serious case was received from a other healthcare professional (medical assistant) via Medical Information (GMI) (Reference number- 00640671).  This case involves a 4 year old male patient who was administered an expired dose (0.5 ml) of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot number: C5624AA; expiry date: 10-JUN-2021) via intramuscular route in the left arm for prophylactic vaccination on 14-JUN-2021 (expired product administered).  Medical history, medical treatment(s), past vaccination(s) and family history were not provided.  It was a case of an actual medication error due to expired vaccine used (latency same day).  No other vaccines were administered.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Left VI palsy onset less than 24 hours after DTaP #4, HIB #4, Prevnar #3.
p/vax pt devel a fever of 101, fussiness & upper resp infect;pt was seen by Md;CBC & urine & blood cult, CXR & LP were performed but results were not provided;
Nausea, headache, low grade fever, chills, body aches, tiredness
This is a spontaneous report from a contactable pharmacist. A 70-year-old female patient received PREVNAR 13 (Lot number S39564, Expiry date Sep 2018, NDC number 00005197101), via an unspecified route of administration at single dose on 04Oct2017 for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced left arm and shoulder are infected on an unspecified date with outcome of not recovered. Therapeutic measures were taken as a result of the events included an antibiotic.; Sender's Comments: Vaccination with PREVNAR 13 might play a contributory role in triggering the occurrence of infection at left arm and shoulder considering the plausible time association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Pfizer BioNTech COVID-19 Vaccine EUA Patient received Pfizer Vaccines on 1/29/2021 and 2/23/2021. Patient presented to ED on 7/16/2021 with symptom onset 7/10/2021 of cough, diagnosed with COVID-19 and acute hypoxic respiratory failure secondary to COVID-19 pneumonia.  While in the hospital, patient was treated with remdesivir, steroids, antibiotics and tocilizumab.  Patient expired on 8/5/21.
Swollen lymph nodes on right side of neck above collar bone.  Noticed  on 4/12/21, two days following the vaccination (4/10/21).  After a brief panic, went online to see whether swollen lymph nodes might be a common reaction following the covid vaccine and the online information seemed to confirm. Online information was very helpful and noted that a Moderna study showed 16% of patients reported swollen lymph nodes after the second dose. After I spoke with my primary care doctor by phone on 4/13/21, she suggested to report through VAERS to contribute to the data/stats.
pt. reports feeling like his heart rate is elevated.  radial pulse in 70s.  pt. reports  a hx of valovagal syncope.  Medics present.  Symptom beginning to resolve with comfort / calming measures.  Will cont. to monitor for an additional 15 mins.  pt. denies any difficulty swallowing / breathing &/or other S/S.
Stated she became ill with headache etc. As days progressed her legs became "numb" and weak. 11/3/2009 MR and DC records for 10/28-10/30/2009. Patient with c/o's weakness, numbness/tingling of extremities, SOB with exertion.  admit for obs and dx testing.DC DX: Inflammatory neuropathy  ICD-9 code 357.8
On 9 May 2014, patient received Hepatitis B #4 (received Hepatitis B #3 at approximately 4.5 months)/PENTACEL #3/ROTATEQ #3/PREVNAR #3 and within five minutes of the injection, it was noticed patient had a blanching/non-whelpy/red round rash on the bottom of both of his feet. He was completely non-toxic, happy, and his lungs were clear. We kept him in the office to watch him and within 20 minutes, he had a similar rash as the above in the genital region. Again, the lungs were clear - he was given BENADRYL (approximately 5mg/kg) and within 30 minutes of the administration of the BENADRYL, the rash was faded, if not gone entirely on the genital area and had faded considerably on his feet. He was discharged to the care of his parents with strict instructions on when to seek emergency care. I called his parents later on in the evening and no new rash had developed. Mom called on the morning of 10 May and reported she gave one dose of BENADRYL during the night and the rash was gone in the morning.
Patient called in 9:30 11-3-20 to report her arm was red, swollen, and sore. She stated she had a fever of 100.4 Per Dr. Patient should take Tylenol for pain and fever if redness spreads she should follow up in office. As of 4 pm 11-3-20 her temp did return to normal.
she had nausea; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient experienced nausea two days after her second dose on an unspecified date. The outcome of the events were unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Under my armpit is swollen and it is a little, like it is sore; Like my lymph node area, that is what it feels like; This is a spontaneous report from a contactable consumer or other non hcp. A 48-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection (Batch/Lot Number: EN8200; Expiration Date: 30Jun2021), via an unspecified route of administration on 17Feb2021 as first dose, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced under my armpit is swollen and it is a little, like it is sore; like my lymph node area, that is what it feels like. The outcome of the event was unknown.   Information on lot/ batch number has been requested.  Follow-up attempts completed. No further information expected.
felt some drops going down; felt some drops going down; A spontaneous report was received from a consumer concerning a 74-year-old male patient who stated he received the Moderna COVID-19 vaccine and as the needle was being withdrawn, he felt some drops going down his arm/underdose.   The patient's medical history was not provided.    Products known to have been used by the patient included statin, morniflumate, blood pressure medicine, and clonazepam.   On 07 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in left arm for prophylaxis of COVID-19 infection.  The consumer received first dose of the Moderna COVID-19 vaccine on 07Feb2021. He received the shot on his left (non-dominant) arm. As the needle was being withdrawn, he felt some drops going down his arm. He is not sure whether he received the full dose or not.   Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not reported.  The outcome for the event was not reported.; Reporter's Comments: This report refers to a case of Vaccine underdose and exposure via skin contact for mRNA-1273 (Lot number: unknown) with no associated AEs.
Pt rec'd PNEUMOVAX on 1-17-13. She developed diffuse redness & swelling on (L) arm at immunization site on 1-19-13. Redness/swelling extended from (L) deltoid down to (L) elbow & lasted x 4 days, according to patient. Patient seen in office on 1-25-13 and sx resolved.
Information has been received from a vaccine coordinator referring to unspecified patients. The patients' concurrent condition and medical history were not reported. Concomitant medication was not provided. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 (dose, unit, route unknown, lot # L044475, expiration date 12-MAY-2017) once. No adverse event was reported. No product quality issue involved. Additional information has been requested. This is one of several reports received from the same reporter.
Client presented for 1st Moderna Covid vaccination.  Data entry discovered that client was only 16 years old.  Client was vaccinated at shelter and left no address or contact information.
FEVER, right abdominal pain, body aches, headaches, fatigue, and gas  ED to Hosp-Admission Discharged   8/17/2021 - 8/19/2021 (2 days)  Hospital  COVID-19 virus infection  Pneumonia due to infectious organism  Pneumonia due to COVID-19 virus  Hospital Course:      Patient is a pleasant 65-year-old female presented due to generalized fatigue tiredness and progressive shortness of breath with nonproductive cough. She denied any chest pain or tightness patient had Oxygen saturation of 94% and elevated white count. Chest x-ray showed linear density in the right middle lobe. Patient did have Covid and chest CTA which showed hazy groundglass type density in the lungs bilaterally seen with viral or interstitial type pneumonitis.   Patient was treated with steroids, supplemental oxygen and bronchodilators along with antibiotics patient slowly continued to improve she did require home oxygen which was set up prior to discharge.   She will continue on antibiotics and supplemental oxygen
COUGH; SNIFFLING; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the subject experienced cough. On 2021, the subject experienced sniffling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from cough, and sniffling. This report was non-serious.
timeline of events: 11/2020 seen by cardiology for atypical chest pain, abnormal ekg, and lower leg edema.  lexiscan and echo done, negative. 12/2/2020 vein mapping done BLE,  negative for clots. med changes done and venodynes ordered. 3/16/2021 vaccine received. approximately 2 weeks later, developed severe GI virus, increasing back pain, left leg tightness and pain.  3/31 follow up with cardiology, told doctor unable to wear venodynes due to severe pain in knee area. 4/1 phone appt with PCP, treated for GI virus. 5/1 went to PCP for increasing pain and difficulty walking. discovered new swelling in left leg, large area medial calf just below left knee.   labs done, normal.  5/12 US left leg done. 5/20 back to PCP; told that US showed large hematoma and surgical consult needed.
No immediate reaction, but Pt woke up with hives the morning after getting the vaccine. The hives spread all over his body and progressed to angioedema on his eyes/mouth. Urgent Care proscribed prednisone, which brought the inflammation down. Dr. (allergist) put Pt on a  Pregimen of Allegra, Zyrtec and Benadryl to bring his hives under control. It took more than 10 weeks for Pt hives to subside, and we are beginning to wean him off his antihistamines.
This case was reported by a pharmacist via call center representative and described the occurrence of swelling arm in a 78-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on an unknown date). On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown. Additional details were provided as follows: The age at vaccination was not applicable to this report. The pharmacist reported that the patient was past the 6 month point for the 2nd dose of the SHINGRIX series, which led to incomplete course of vaccination. The pharmacist consented to follow up. Follow up information was received from the pharmacist on 29th January 2019: The age at vaccination was not reported, however the patient could be 77 or 78 years old at the time of vaccination. On an unknown date, the patient received the 2nd dose of SHINGRIX past the 6 months period from the 1st dose, which led to lengthening of vaccination schedule. Less than a year after receiving SHINGRIX, the patient experienced swollen arm. The patient called the pharmacist for the advice and pharmacist called the GlaxoSmithKline (GSK) to verify that the patient's swollen am was normal. The pharmacist reported that the patient was not his/her patient. The pharmacist did not vaccinate the patient. It was unknown if the reporter considered the swelling arm to be related to SHINGRIX. The pharmacist did not consent for follow up. The VAERS information was unknown.
About 20 minutes after injection (2nd injection in series), her mouth, tongue, and throat began to tingle. She broke out in a red rash from the injection site up to chest, neck and face.
I tested positive on 26DEC2022  for COVID-19 with symptoms the previous day of sore throat and stuffy nose and a low fever of one hundred degrees.   I developed symptoms the following day with of body aches, cough, sore throat, nasal drip, and tiredness. The nasal drip lead to a sore throat and more coughing.  27DEC2022 temperature of ninety nine point seven degrees and stuffy nose and body aches. 28DEC2022 One hundred degree temperature more body aches fatigue stuffy nose cough sore throat. 29DEC2022 Ninety eight point two temperature same symptoms continued but with chills in addition. 30DEC2022 same symptoms  continued and temperature was ninety eight point one  plus diarrhea this day. 01JAN2023 stuffy nose and cough were the remaining symptoms.
An enlargement showed up on my lower right neck below the Adam's apple. It was painful when chewing or sneezing or pressing it. I put cold compress every night and drank lots of water.  It disappeared on the 3rd day.
Pt c/o feeling dizzy and "nearly fell down stairs" coming from the observation area. RN assess pt at 2:58pm, VSS. Pt was offered water and juice, declined juice but accepted water. Pt continued to complain of dizziness, Aid call was made at 3:05pm and medics moved pt to cot to lie down.  Aid attempt to sit pt up at 3:25pm and pt reported continued dizziness and requested to lie back down. Aid called to transfer pt to hospital at 3:30pm.  arrived at 3:35pm and transferred pt t  medical center. At time of transport pt was able to communicate clearly, oriented to person, place, and time Pt advised to follow up with PCP regarding vaccination prior to 2nd dose.  From onset of symptoms to hospital transport time was approximately 35 minutes.
Patient received ZOSTAVAX on 3/29/11. She said she noticed pain on day of administration. On the next day she hit the area of the injection site and that is when she noticed a red area extending about 1-2 inches. On 4/13/11, it remained the same and felt lumpy. She was advised to have medical doctor look at it.
12cm x 4cm x 4cm red swollen nodule to lt deltoid;no discharge, +redness, +tenderness, negative streaking;no tx;
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored GARDASIL 9 lot # N020139 with expiration date 14-FEB-2020, for prophylaxis (dose and route of administration were not reported). No adverse effects were reported. At the time of reporting, the temperature excursion and the time frame were unknown. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1802USA013755: US-009507513-1803USA000351: US-009507513-1803USA000352: US-009507513-1803USA000353: US-009507513-1803USA000354: US-009507513-1803USA000355: US-009507513-1803USA000357: US-009507513-1803USA000358:
"Provider d/c note:  79 YO female with h/o  HLD, HTN, CKD, hypertrophic cardiomyopathy, short term memory loss. She tested positive for COVID on 10/5 with initial Sx onset 2-3 days prior to being positive.  Had reached out to her PCP and Paxlovid was set to be initiated.  But was brought to the hospital due to worsening weakness.  In the emergency department she was found to be hemodynamically stable, labs within normal limits except for elevated BNP > 3000, and tested positive for COVID-19.  Patient was not requiring any oxygen throughout her stay.  Chest x-ray within normal limits.  Given her prior history of cardiomyopathy repeat echocardiogram was ordered which is pending to be read but initial report with EF > 60%. Patient given IV lasix  40 mg with improvement of symptoms.   She was evaluated with Physical therapy who recommended home with assist.  Patient remains stable, she tolerated oral intake. She will be discharged today back to home.  Will recommend patient to discuss with PCP again regarding Paxlovid."
Received vaccines-went to ER pm-fussy, tonic-clonic movements lasting few seconds-happened every few minutes for 30-45 minutes. Became limp and pale-shallow breathing. Went to ER-LP, CT scan, CBC, blooc tests. WNL Given IV Rocephin. Tempin ER 99 deg had OM was (WBC 30.2) finishing up Amox-seen here for follow-up 6/26. Referred to hospital for EEG. Dx-seizure.
I first noticed changes in my menstrual cycle like the flow, duration, and how quite late they were. I had a late period that was delayed after a month. When it resumed it was heavier, duration was longer, and the intensity of the pain during my periods was also higher. Over the last six months it has kept that same consistency as well with being heavy and longer. The symptoms that come along with the periods has really been hitting me harder this time than what it used to feel like before the vaccine. If I look at other events I also notice if I do get sick, then I get sick for longer. I feel like I get sick a lot faster. I have gotten several colds since getting the vaccine. I felt like I had a general head cold and flu like symptoms. I've done many COVID-19 test and they are all negative. I was sick early November 2021 when I thought I had allergies. I didn't have taste or smell, and I didn't think anything of it. I could taste food, but it was faint, and things started to smell weird and different. Then a friend that I had hung around said she had tested positive for COVID-19 and said she was experiencing those same symptoms I had when she had it. I never tested for COVID-19 again because I was getting better at that point. When I was sick, I was taking allergy and cold medicines.